Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1P 140----1件: 49
2P-1037----1件: 299
3P-188 NF----1件: 113
4P-552----1件: 53
5P144----1件: 51
6P144 cream----1件: 51
7P144 Cytokine Inhibitor----1件: 51
8P144 Cytokines Inhibitors----1件: 51
9P144 DIGNA CREAM----1件: 51
10P144. Cytokines Inhibitors----1件: 51
11P28GST----1件: 96
12P2B001----1件: 6
13P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: D05575 ,
D08469 ,
D10829 		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
14P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline		3件: D05575 ,
D08469 ,
D10829 		4件: DRD2,
DRD3,
DRD4,
MAOB 💬		18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
15P32----1件: 37
16P32/98----1件: 37
17P32/98 3%----1件: 37
18P38 (4) Map Kinase Inhibitor----1件: 46
19P38 Inhibitor (4)----1件: 46
20P38 Inhibitor (4) 150mg----1件: 46
21P38 Inhibitor (4) 25mg----1件: 46
22P38 Inhibitor (4) 300mg----1件: 46
23P38 Inhibitor (4) 50mg----1件: 46
24P38 Inhibitor (4) 75mg----1件: 46
25P38 Map Kinase Inhibitor----1件: 46
26P38(4) Map Kinase Inhibitor----1件: 46
27PA101----1件: 85
28PAAG15----1件: 299
29Pabinafusp alfa1件: Pabinafusp alfa1件: D11812 2件: IDS,
TFRC 💬		8件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬1件: 19
30Paclitaxel1件: Paclitaxel1件: D00491 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 46, 85
31Padsevonil1件: Padsevonil1件: D11842 3件: SV2A,
SV2B,
SV2C 💬		1件: ECM-receptor interaction 💬1件: 149
32PAH----3件: 49, 53, 86
33PAH medication----1件: 86
34PAH Therapies----1件: 86
35Palifermin1件: Palifermin1件: D05338 1件: FGFR2 💬13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬5件: 13, 36, 38, 39, 65
36Palmitate1件: Palmitic Acid1件: D05341 --1件: 63
37Palmitoleic Acid1件: Palmitoleic Acid---1件: 97
38Palmitoylethanolamide1件: Palmidrol1件: D08328 --1件: 2
39Palopegteriparatide----1件: 235
40Palopegteriparatide (TransCon PTH)----1件: 235
41PALOVAROTENE1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
42PALOVAROTENE - 1.5mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
43PALOVAROTENE - 10 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
44PALOVAROTENE - 1mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
45PALOVAROTENE - 2 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
46PALOVAROTENE - 2.5 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
47PALOVAROTENE - 3 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
48PALOVAROTENE - 4 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
49PALOVAROTENE - 5 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
50PALOVAROTENE 1.5 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
51Palovarotene dose level 11件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
52Palovarotene dose level 21件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
53Palovarotene dose level 31件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
54Palovarotene dose level 41件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
55PALOVAROTENE-2 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
56PALOVAROTENE-3 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
57PALOVAROTENE-4 mg1件: Palovarotene1件: D09365 1件: RARG 💬-1件: 272
58Palynziq1件: Pegvaliase1件: D11077 1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240
59Pamidronate1件: Pamidronic acid1件: D07281 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 270, 271, 274
60Pamidronate (Aredia)1件: Pamidronic acid1件: D07281 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274
61PAMREVLUMAB1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113
62Pamrevlumab (FG-3019)1件: Pamrevlumab1件: D10969 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬1件: 113
63Panax Quinquefolius1件: Panax quinquefolius whole---1件: 46
64Pancreas Powder----1件: 299
65Pancrease----1件: 299
66PANCREASE MT----1件: 299
67Pancrease MT 10.5, or MT 21----1件: 299
68PANCREASLIPASE----1件: 299
69Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)2件: Acarbose,
Pancrelipase		2件: D00216 ,
D05349 		5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬		7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298
70Pancreatic enzymes----1件: 298
71Pancreatin1件: Pancrelipase1件: D05349 --2件: 298, 299
72PANCREATIN (PAncreas Powder)1件: Pancrelipase1件: D05349 --1件: 299
73PANCREATINA----1件: 299
74PANCREATINA (Páncreas Polvo----1件: 299
75PANCREATINA (Páncreas Polvo)----1件: 299
76PANCREAZE----1件: 299
77PANCREAZE®----1件: 299
78PANCRECARB® (pancrelipase)1件: Pancrelipase1件: D05349 --1件: 299
79Pancrelipase1件: Pancrelipase1件: D05349 --2件: 298, 299
80PANCRELIPASE AMYLASE1件: Pancrelipase1件: D05349 --1件: 299
81Pancrelipase Delayed Release1件: Pancrelipase1件: D05349 --1件: 299
82Pancrelipase Delayed Release Capsule1件: Pancrelipase1件: D05349 --2件: 298, 299
83Pancrelipase Microtablets1件: Pancrelipase1件: D05349 --1件: 299
84Pancrelipase with bicarbonate1件: Pancrelipase1件: D05349 --1件: 299
85Pancrelipase/Pancreas Powder1件: Pancrelipase1件: D05349 --2件: 298, 299
86Pandemrix,----1件: 46
87Panhematin1件: Hemin1件: D10003 2件: ALAS1,
ALAS2 💬		4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254
88Pankreatin----1件: 299
89Pantethine1件: Pantethine1件: D01234 --1件: 120
90Pantoprazole1件: Pantoprazole1件: D05353 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65
91Pantoprazolo 20 mg gastro-resistant tablets----1件: 65
92PANZYGA----1件: 14
93Panzytrat----1件: 298
94Panzytrat 25.000----1件: 298
95Panzytrat 25.000 FIP-E units of Lipase----1件: 298
96PANZYTRAT 25000----1件: 299
97Panzytrat® 25,000----1件: 299
98Panzytrat® ok----1件: 299
99Paquinimod1件: Paquinimod---2件: 49, 51
100Paquinimod (ABR-215757)1件: Paquinimod---1件: 49
101PARACETAMOL1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬6件: 3, 6, 13, 35, 46, 49
102Paracetamol (acetaminophen)1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
103Paracetamol 120Mg/5mL Oral Suspension1件: Acetaminophen1件: D00217 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 3
104PARACETAMOLO----9件: 2, 11, 14, 19, 28, 53, 61, 63, 300
105Paracetamolo 500 mg----1件: 13
106PARACETAMOLO DC.IT FU----1件: 46
107PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE----1件: 19
108PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----1件: 300
109Paracetamolo Zentiva Italia----1件: 28
110Paraclisib----1件: 61
111Paraffin Oil1件: Mineral oil1件: D05042 --1件: 291
112PARALEN 500----1件: 46
113Parapres----1件: 6
114Parathyroid hormon 1-84----1件: 235
115Parathyroid hormone1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 70, 235
116Parathyroid Hormone (1-84) Human Recombinant1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
117Parathyroid Hormone (rDNA)1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
118Parathyroideahormon----1件: 235
119PARCOPA----1件: 6
120Pardaprunox----1件: 6
121Pardoprunox1件: Pardoprunox1件: D09397 3件: DRD2,
DRD3,
HTR1A 💬		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6
122Pardoprunox hydrochloride1件: Pardoprunox1件: D09397 3件: DRD2,
DRD3,
HTR1A 💬		10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6
123Parecoxib1件: Parecoxib1件: D03716 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271
124Parenteral Remodulin (treprostinil) injection1件: Treprostinil1件: D06213 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
125Parenteral Treprostinil1件: Treprostinil1件: D06213 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
126Paricalcitol1件: Paricalcitol1件: D00930 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298
127Parnaparin1件: Parnaparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 97
128PARNAPARIN SODIUM1件: Parnaparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 97
129Paroxetine1件: Paroxetine1件: D02362 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85
130Paroxetine & Prednisolone2件: Paroxetine,
Prednisolone		2件: D00472 ,
D02362 		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46
131Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: D00472 ,
D02362 		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46
132Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone		2件: D00472 ,
D02362 		2件: NR3C1,
SLC6A4 💬		3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46
133Parsaclisib1件: Parsaclisib1件: D11437 1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬3件: 35, 53, 61
134Parsaclisib (1 mg)1件: Parsaclisib1件: D11437 1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61
135Parsaclisib (2.5 mg)1件: Parsaclisib1件: D11437 1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61
136Parsaclisinib----1件: 61
137Part 1 Levulan injection----1件: 34
138Part 1 Levulan surface application----1件: 34
139Part 1 Levulan surface application twice----1件: 34
140Part 1 Levulan surface application twice with microneedling----1件: 34
141Part 1, JM-010 component Group A----1件: 6
142Part 1, JM-010 component Group B----1件: 6
143Part 1, JM-010 component Group C----1件: 6
144Part 1: LJN452----1件: 93
145Part 2 Adult Alogabat High Dose (aged 15-17)----1件: 201
146Part 2, JM-010 combination Group A----1件: 6
147Part 2, JM-010 combination Group B----1件: 6
148Part 2, JM-010 component Group C----1件: 6
149Part 2: LJN452 Dose level 1----1件: 93
150Part 2: LJN452 Dose level 2----1件: 93
151Part A----1件: 46
152Part A: 100 mg/mL GSK2618960----1件: 13
153Part B----1件: 46
154Part B Open-Label Extension----1件: 51
155Part B: Dose of GSK2618960 decided from Part A----1件: 13
156Part C: Dose of GSK2618960 decided from Part A and B----1件: 13
157Part I - etoricoxib 60 mg1件: Etoricoxib1件: D03710 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
158Part I - etoricoxib 90 mg1件: Etoricoxib1件: D03710 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
159Part I- naproxen 1000 mg1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
160Part II- etoricoxib 60 mg1件: Etoricoxib1件: D03710 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
161Part II- etoricoxib 90 mg1件: Etoricoxib1件: D03710 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
162Part II- naproxen 1000 mg1件: Naproxen1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
163Partial Enteral Nutrition----1件: 96
164Pasireotida1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
165Pasireotida 3001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
166Pasireotida 6001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
167Pasireotida 9001件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
168Pasireotide1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 74, 75
169Pasireotide 0.3mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
170Pasireotide 0.6 MG/ML1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
171Pasireotide 0.6mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
172Pasireotide 0.9 mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
173Pasireotide 20mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
174Pasireotide 40mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
175Pasireotide 60mg1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
176PASIREOTIDE DIASPARTATE1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
177Pasireotide LAR1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 75
178PASIREOTIDE PAMOATE1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
179Pasireotide s.c.1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
180Pasireotide sub-cutaneous1件: Pasireotide1件: D10147 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75
181Pasireotide with or without cabergoline2件: Cabergoline,
Pasireotide		2件: D00987 ,
D10147 		6件: DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75
182Pasireotode----1件: 75
183PAT----1件: 160
184PAT-001, 0.1%----1件: 160
185PAT-001, 0.2%----1件: 160
186Patient Current Care----1件: 46
187Patient treated with DMARD----1件: 46
188Patients will be randomized to receive EHP-101----1件: 51
189Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----1件: 46
190Pazopanib1件: Pazopanib---1件: 227
191PB----2件: 67, 225
192PB006----1件: 13
193PB1046----1件: 86
194PB1046 Injection----1件: 113
195PB1046 Subcutaneous Injection----1件: 86
196PB1046, VIP-ELP1-120, Vasomera----1件: 86
197PBA----1件: 231
198PBF-509----1件: 6
199PBF-677----1件: 97
200PBF-999----1件: 8
201PBF-999 / 160 mg----1件: 8
202PBF-999 / 320 mg----1件: 8
203PBFT02----1件: 127
204PBGM01----1件: 19
205PBI4050----2件: 85, 299
206PBKR03----1件: 19
207PBMC autotransplantation----1件: 2
208PBT2----1件: 8
209PC945----1件: 299
210PCA----1件: 70
211PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65
212PCO371----1件: 235
213PCR polymorphism----1件: 46
214PCT (PureCell Technologies Complex)----1件: 97
215PCV----1件: 13
216PD 0299685----1件: 226
217PD 0299685 at 15mg BID----1件: 226
218PD 0299685 at 30mg BID----1件: 226
219PD 0360324----2件: 46, 84
220PD patients H&Y=1.5-2 Medications OFF----1件: 6
221PD patients H&Y=1.5-2 Medications ON----1件: 6
222PD patients H&Y=3 Medications OFF----1件: 6
223PD patients H&Y=3 Medications ON----1件: 6
224PD vitamin supplementation----1件: 6
225PD-02996851件: PD-0299685---1件: 226
226PD-03259011件: Mirdametinib1件: D11675 2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
227PD00377 Na-salt----1件: 85
228PDA001----2件: 46, 96
229PDA001 (cenplacel-L)----1件: 84
230PDE5 inhibitor----1件: 86
231PEA-LUT----1件: 127
232Pectin1件: Pectin1件: D02316 --1件: 96
233Pednisone----2件: 43, 44
234Peficitinib1件: Peficitinib1件: D10653 3件: JAK1,
JAK2,
JAK3 💬		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
235PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337
236Peg-Ada----1件: 65
237Peg-Interferon alpha-2b1件: Interferon alfa-2b1件: D02745 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 34
238PEG-interleukin-21件: Human interleukin-2---1件: 65
239PEG-liposomal Prednisolone Sodium Phosphate2件: Phosphate ion,
Prednisolone		1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97
240PEG-rhG-CSF----1件: 60
241PEG-somatropin1件: Somatotropin---1件: 78
242Pegcetacoplam----1件: 2
243PEGCETACOPLAN1件: Pegcetacoplan1件: D11613 1件: C3 💬17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬4件: 2, 61, 62, 222
244Pegcetacoplan (APL-2)1件: Pegcetacoplan1件: D11613 1件: C3 💬17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 61, 62
245Pegfilgrastim1件: Pegfilgrastim1件: D06889 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 60
246Peginesatide1件: Peginesatide1件: D09946 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
247PEGINTERFERON BETA-1A1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
248Peginterferone beta 1a----1件: 13
249PEGINTERFERONE BETA-1A----1件: 13
250PEGINTERFERONE LAMBDA-1A----1件: 13
251Pegsunercept1件: Pegsunercept1件: D05393 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
252Pegsunercept (PEG sTNF-RI)1件: Pegsunercept1件: D05393 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
253Pegtarviliase----1件: 337
254Pegtibatinase----1件: 337
255PEGUNIGALSIDASE ALFA1件: Pegunigalsidase alfa1件: D11685 --1件: 19
256Pegunigalsidase alpha----1件: 19
257PEGVALIASE1件: Pegvaliase1件: D11077 1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240
258Pegvaliase-Pqpz1件: Pegvaliase1件: D11077 1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240
259Pegvisomant1件: Pegvisomant1件: D05394 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 78, 265
260PEGylated Intereron Beta-1a----1件: 13
261Pegylated interferon alfa1件: Interferon alfa1件: D03305 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 96
262Pegylated Interferon Alpha2b----1件: 227
263PEGylated Interferon Beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
264Pegylated polypeptide hormone of human recombinant origin PEG-hGH----1件: 78
265Pegylated recombinant human growth hormone1件: Somatotropin---1件: 78
266PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH202件: Hyaluronidase,
Hyaluronidase (human recombinant)		3件: D04455 ,
D04456 ,
D06604 		--1件: 28
267Pegylated Somatropin1件: Somatotropin---1件: 78
268Pelubiprofen1件: Pelubiprofen1件: D01865 --1件: 46
269Pelubiprofen 30 mg1件: Pelubiprofen1件: D01865 --1件: 46
270Pemafibrate1件: Pemafibrate1件: D10711 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
271Pembrolizumab1件: Pembrolizumab1件: D10574 1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 25, 285
272PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----1件: 171
273PEMIROLAST1件: Pemirolast1件: D07476 --1件: 113
274Pemziviptadil (PB1046) Injection----1件: 86
275PEN+usual care----1件: 96
276Pending----6件: 13, 19, 96, 97, 113, 302
277Penicillamine1件: Penicillamine1件: D00496 --2件: 51, 171
278Pentamidina1件: Pentamidine1件: D08333 --1件: 61
279PENTAMIDINA ISETIONATO1件: Pentamidine1件: D08333 --1件: 61
280Pentamidine1件: Pentamidine1件: D08333 --2件: 61, 65
281Pentasa1件: Mesalazine1件: D00377 --2件: 96, 97
282Pentasa 2g sachet prolonged release granules (95%)2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
283Pentasa 500 mg Retardtabletten1件: Mesalazine1件: D00377 --1件: 97
284Pentasa Compact 2g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
285Pentasa Compact 4g, granulate with prolonged release2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
286Pentasa enema1件: Mesalazine1件: D00377 --1件: 97
287Pentasa prolonged release granules 2g2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
288PENTASA Sachet1件: Mesalazine1件: D00377 --2件: 96, 97
289Pentasa Sachet 1 g1件: Mesalazine1件: D00377 --2件: 96, 97
290Pentasa Sachet 1 g prolonged release granules2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 96
291Pentasa Sachet 1g1件: Mesalazine1件: D00377 --1件: 97
292Pentasa Sachet 2 g1件: Mesalazine1件: D00377 --1件: 97
293Pentetreotide1件: Pentetreotide1件: D01859 --1件: 75
294Pentosan Polysulfat SP 54® injection solution----1件: 19
295Pentosan polysulfate1件: Pentosan polysulfate---3件: 19, 26, 226
296PENTOSAN POLYSULFATE SODIUM1件: Pentosan polysulfate---1件: 19
297Pentosan polysulfate sodium 100 mg1件: Pentosan polysulfate---1件: 226
298Pentosan Polysulphate SP54----1件: 19
299Pentosan Polysulphate SP54®----1件: 19
300Pentoxifylline1件: Pentoxifylline1件: D00501 --12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298
301Pentoxifylline 400 MG1件: Pentoxifylline1件: D00501 --1件: 97
302Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113
303Peptidic+Probiotic----1件: 96
304Perampanel1件: Perampanel1件: D08964 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬		16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 6, 144
305Percutaneous sirolimus1件: Sirolimus1件: D00753 1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 278
306Perdix----1件: 19
307Peresolimab----1件: 46
308PERFALGAN----1件: 2
309Perflubutane1件: Perflubutane1件: D05440 --2件: 298, 300
310Perfluorinated gas/oxygen mixture1件: Oxygen1件: D00003 --1件: 299
311Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265
312Perfusion of treatment Ocrelizumab1件: Ocrelizumab1件: D05218 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
313Perfusion of treatment Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
314PERGOLIDE1件: Pergolide1件: D08339 2件: DRD1,
DRD2 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
315Perhexiline1件: Perhexiline1件: D08340 8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬		47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 58, 272
316Peri-neural Dexamethasone 1 mg1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
317Perindopril1件: Perindopril1件: D03753 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222
318Perindopril 2mg Tablets1件: Perindopril1件: D03753 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113
319PERINDOPRIL ARGININA2件: Arginine,
Perindopril		2件: D02982 ,
D03753 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58
320Perindopril arginine2件: Arginine,
Perindopril		2件: D02982 ,
D03753 		1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58
321Peripheral blood stem cell----1件: 285
322Peripheral Blood Stem Cells----2件: 51, 65
323Permitted DMARDs----1件: 46
324Persantin----1件: 46
325Persantin 100 mg----1件: 46
326Persantin 100 mg and----1件: 46
327Personalized extended interval dosing of natalizumab1件: Natalizumab1件: D06886 1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13
328Pertactin1件: Bordetella pertussis pertactin antigen---1件: 46
329Pertactin adsorbed1件: Bordetella pertussis pertactin antigen---1件: 46
330PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated),
Hydroxide ion		1件: D02416 --1件: 46
331PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis pertactin antigen,
Hydroxide ion		1件: D02416 --1件: 46
332Pertussis toxoid1件: Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)---1件: 46
333PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE4件: Aluminium,
Aluminum hydroxide,
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated),
Hydroxide ion		1件: D02416 --1件: 46
334Pertussis vaccine1件: Pertussis vaccine1件: D06514 --2件: 13, 46
335PERTZYE----1件: 299
336Perxexiline----1件: 58
337PET----1件: 6
338PET with 11C-Flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13
339PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85
340PET10----1件: 41
341PET3----1件: 41
342Petrolatum1件: Petrolatum1件: D05331 --1件: 158
343Pexsig----1件: 58
344PF 06687234----2件: 96, 97
345PF-004897911件: PF-00489791---1件: 86
346PF-00547659----2件: 96, 97
347PF-00547659 SC injection----2件: 96, 97
348PF-02545920----1件: 8
349PF-04171327----1件: 46
350PF-04171327 10 mg----1件: 46
351PF-04171327 25 mg----1件: 46
352PF-04236921----2件: 49, 96
353PF-04236921 SC injection----1件: 96
354PF-04383119----1件: 226
355PF-05208763----1件: 67
356PF-05230917----1件: 97
357PF-05280586----1件: 46
358PF-05285401----1件: 97
359PF-062526161件: Domagrozumab1件: D11047 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 113
360PF-06291826-83/Fx-1006A1件: Fx-1006A---1件: 28
361PF-06342674 0.25 mg/kg----1件: 13
362PF-06342674 1.5 mg/kg----1件: 13
363PF-06342674 6.0 mg/kg----1件: 13
364PF-06410293----1件: 46
365PF-06412562----1件: 6
366PF-06438179----1件: 46
367PF-06462700----1件: 60
368PF-06480605----1件: 97
369PF-06480605 100 mg/ml----1件: 97
370PF-066497511件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
371PF-06649751 - 15mg1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
372PF-06649751 - 1mg1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
373PF-06649751 - 5mg1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
374PF-06649751 high dose (15 mg QD)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
375PF-06649751 low dose (1 mg QD)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
376PF-06649751 middle dose 1 (3 mg QD)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
377PF-06649751 middle dose 2 (7 mg QD)1件: Tavapadon1件: D11431 2件: DRD1,
DRD5 💬		10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6
378PF-066508331件: PF-06650833---1件: 46
379PF-06650833 100 mg1件: PF-06650833---1件: 46
380PF-06650833 20 mg1件: PF-06650833---1件: 46
381PF-066516001件: PF-06651600---3件: 46, 96, 97
382PF-06651600 10 mg1件: PF-06651600---1件: 97
383PF-06651600 50 mg1件: PF-06651600---2件: 96, 97
384PF-06651600 50mg1件: PF-06651600---1件: 96
385PF-06651600-151件: PF-06651600---2件: 96, 97
386PF-06669571----1件: 6
387PF-06687234----1件: 97
388PF-067008411件: PF-06700841---3件: 49, 96, 97
389PF-06700841 15 mg1件: PF-06700841---1件: 49
390PF-06700841 25 mg1件: PF-06700841---2件: 96, 97
391PF-06700841 25mg1件: PF-06700841---1件: 49
392PF-06700841 30 mg1件: PF-06700841---1件: 49
393PF-06700841 45 mg1件: PF-06700841---1件: 49
394PF-06700841 5 mg1件: PF-06700841---3件: 49, 96, 97
395PF-06700841 5mg1件: PF-06700841---1件: 49
396PF-06700841-151件: PF-06700841---3件: 49, 96, 97
397PF-06730512----1件: 222
398PF-06755347 intravenous healthy participant----1件: 63
399PF-06755347 subcutaneous healthy participant----1件: 63
400PF-06755347 subcutaneous ITP----1件: 63
401PF-06823859----1件: 50
402PF-06823859 high----1件: 50
403PF-06823859 low----1件: 50
404PF-06826647----1件: 97
405PF-06826647 100 mg QD----1件: 97
406PF-06826647 300 mg QD----1件: 97
407PF-06826647 600 mg QD----1件: 97
408PF-06835375----3件: 46, 49, 63
409PF-06836922----1件: 78
410PF-06939926----1件: 113
411PF-07054894----1件: 97
412PF-07256472----1件: 276
413PF-6826647 400 mg QD----1件: 97
414PFD----3件: 51, 117, 298
415Pfefferminzblätter 1ml/10ml----1件: 97
416PFP----1件: 299
417PG----1件: 46
418PG-760564----1件: 46
419PG2----1件: 63
420PG203----1件: 6
421PGM169/GL67A----1件: 299
422PGT-1 gene lipid complex----1件: 299
423PGx-guided post-operative pain management----2件: 96, 97
424PH-7978041件: PH-797804---1件: 46
425Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6
426Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid----1件: 6
427PHA-022121----1件: 65
428PHA-022121 high dose----1件: 65
429PHA-022121 low dose----1件: 65
430PHA-022121 medium dose----1件: 65
431PHA-022121 selected dose----1件: 65
432PHA-794,428----1件: 78
433PHA-794428----1件: 78
434Phagocyte Oxidase Subunit Transduced CD34 Hematopoietic Stem Cells----1件: 65
435Pharmacodynamics----1件: 34
436Pharmacokinetics of certolizumab pegol1件: Certolizumab pegol1件: D03441 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
437Pharmacokinetics study----1件: 50
438Pharmacologic approaches to glycemic treatment----1件: 298
439Phase 1, SQY51----1件: 113
440Phase 1: Conventiaonal DMARD----1件: 46
441Phase 1: Etanercept1件: Etanercept1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
442Phase 1: Methotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
443Phase 2----1件: 13
444Phase 2: Optional ETN, SSZ, HCQ, MTX----1件: 46
445Phase 2a, SQY51 (cohort 1)----1件: 113
446Phase 2a, SQY51 (cohort 2)----1件: 113
447Phase 2a, SQY51 (cohort 3)----1件: 113
448Phase 3----1件: 13
449Phase1 : CDED/Modulen™IBD® + Maintenance therapy----1件: 96
450Phase2 and 3 :----1件: 96
451Phe----1件: 75
452Pheburane1件: Phenylbutyric acid---1件: 21
453Phenlarmide Tablets----1件: 6
454Phenoptin----2件: 124, 240
455Phenothiazine1件: Phenothiazine1件: D02601 --1件: 127
456Phentermine1件: Phentermine1件: D05458 5件: MAOA,
MAOB,
SLC6A2,
SLC6A3,
SLC6A4 💬		16件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬1件: 97
457Phentermine-Topiramate2件: Phentermine,
Topiramate		2件: D00537 ,
D05458 		41件: CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
MAOA,
MAOB,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SLC6A2,
SLC6A3,
SLC6A4 💬		63件: Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 97
458Phenylalanine1件: Phenylalanine1件: D00021 --1件: 240
459Phenylalanine restricted diet1件: Phenylalanine1件: D00021 --1件: 240
460Phenylalanine-free protein substitute in tablet form (XPhe minis)1件: Phenylalanine1件: D00021 --1件: 240
461Phenylalanine-free protein substitute tablets1件: Phenylalanine1件: D00021 --1件: 240
462PHENYLBUTYRATE1件: Phenylbutyric acid---12件: 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338
463Phenylbutyrate Oral Tablet1件: Phenylbutyric acid---1件: 15
464PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR1件: Lysine1件: D02304 --1件: 13
465Phenylephrine1件: Phenylephrine1件: D08365 3件: ADRA1A,
ADRA1B,
ADRA1D 💬		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 22
466Phenylketonuria-type diet----1件: 240
467Phenytoin1件: Phenytoin1件: D00512 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13
468Pheripheral blood stem cells----1件: 65
469PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid1件: Propanoic acid---1件: 6
470PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid----1件: 6
471Phosphate1件: Phosphate ion---32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
472Phosphate and betamethasone acetate, 2 mL.3件: Acetate,
Betamethasone,
Phosphate ion		1件: D00244 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235
473Phosphate sandoz1件: Phosphate ion---1件: 78
474Phosphate tablets.1件: Phosphate ion---1件: 238
475Phosphate-buffered saline1件: Phosphate ion---1件: 49
476Phosphate.1件: Phosphate ion---1件: 238
477Phosphatidylcholine1件: Lecithin1件: D04682 --1件: 97
478Phosphodiesterase Inhibitors----1件: 51
479Phospholipids1件: Omega-3 fatty acids---1件: 79
480Phosphorodiamidate Morpholino Oligomer----1件: 113
481Phosphorodiamidate morpholino oligomer for exon 45 skipping----1件: 113
482Phosphorodiamidate morpholino oligomer for exon 53 skipping----1件: 113
483Phosphorus1件: Phosphorus---1件: 238
484Photodynamic therapy with Gliolan1件: Aminolevulinic acid1件: D07567 --1件: 97
485PHP-303----1件: 231
486PHVS416----1件: 65
487Phylloquinone1件: Phylloquinone---1件: 96
488Phylloquinone (vitamin K1)1件: Phylloquinone---1件: 96
489Physician standard-of-care----1件: 96
490Physiologic serum nebulized nasally----1件: 299
491Physiological saline----1件: 51
492Physiological serum (Sodium chloride)2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 193
493Physiological solution----1件: 299
494PHYSIOLOGISCHE Kochsalzloesung Fresenius - Infusionsloesung----1件: 227
495Physiologische Kochsalzlösung Fresenius - Infusionslösung----1件: 288
496Phytomenadione1件: Phylloquinone---1件: 288
497PI-08241件: PI-0824---1件: 35
498PI-2301----1件: 13
499Picibanil----1件: 278
500Piclidenoson1件: Piclidenoson1件: D10971 1件: ADORA3 💬3件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
501Piclozotan1件: Piclozotan---1件: 6
502Picoprep----1件: 98
503Picosulfate1件: Picosulfuric acid---2件: 97, 291
504PID----1件: 65
505Pig whipworm eggs----1件: 46
506Pilocarpine1件: Pilocarpine1件: D00525 2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
507Pilocarpine Hydrochloride1件: Pilocarpine1件: D00525 2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 53
508Pilocarpine Nitrate 5%2件: Nitrate,
Pilocarpine		2件: D00525 ,
D02313 		2件: CHRM2,
CHRM3 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
509Pimavanserin1件: Pimavanserin---1件: 6
510Pimavanserin (ACP-103)1件: Pimavanserin---1件: 6
511Pimavanserin tartrate1件: Pimavanserin---1件: 6
512Pimavanserin tartrate (ACP-103)1件: Pimavanserin---1件: 6
513Pimecrolimus1件: Pimecrolimus1件: D05480 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160
514Pimecrolimus 1% Cream1件: Pimecrolimus1件: D05480 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160
515Pimozide1件: Pimozide1件: D00560 2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
516Pimozide 2 mg per day1件: Pimozide1件: D00560 2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
517Pimozide 2mg/day (current) or 4 mg/day (study initiation)1件: Pimozide1件: D00560 2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
518Pimozide 4 mg per day1件: Pimozide1件: D00560 2件: ADRA2A,
DRD2 💬		9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
519Pioglitazone1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
520Pioglitazone 15 mg1件: Pioglitazone1件: D08378 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 96
521Pioglitazone and Tretinoin2件: Pioglitazone,
Tretinoin		2件: D00094 ,
D08378 		4件: PML,
PPARG,
RARA,
RARB 💬		21件: AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬1件: 2
522Pioglitazone or metformin2件: Metformin,
Pioglitazone		2件: D04966 ,
D08378 		3件: PPARG,
PRKAA1,
PRKAA2 💬		27件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 265
523PIPE-307----1件: 13
524PIPERACILLIN1件: Piperacillin2件: D02251 ,
D08380 		--1件: 299
525PIPERACILLIN SODIUM1件: Piperacillin2件: D02251 ,
D08380 		--1件: 299
526Piperacillin sodium , tazobactam sodium2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
527Piperacillin with Tazobactam (tazocin)1件: Piperacillin2件: D02251 ,
D08380 		--1件: 299
528Piperacillin-tazobactam combination product2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
529Piperacillin/Tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
530Piperacillin/Tazobactam Kabi - Fresenius Kabi Austria2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
531Piperacilline/Tazobactam Fresenius Kabi 2 g/0,25 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
532Piperacilline/Tazobactam Fresenius Kabi 4 g/0,5 g poeder voor oplossing voor infusie1件: Tazobactam1件: D00660 --1件: 299
533Piperazine1件: Piperazine1件: D00807 --2件: 58, 272
534PIR, S-7701----1件: 85
535Pirepemat----1件: 6
536Pirepemat x fumarate----1件: 6
537Pirepemat, 100 mg----1件: 6
538Pirepemat, 50 mg----1件: 6
539Pirfenidone1件: Pirfenidone1件: D01583 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
540Pirfenidone (PFD)1件: Pirfenidone1件: D01583 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 51
541Pirfenidone 267 MG [Esbriet]1件: Pirfenidone1件: D01583 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 228
542Pirfenidone and nintedanib2件: Nintedanib,
Pirfenidone		2件: D01583 ,
D10481 		14件: CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		106件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85
543Pirfenidone or nintedanib2件: Nintedanib,
Pirfenidone		2件: D01583 ,
D10481 		14件: CCL2,
FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
IL10,
IL1A,
IL1B,
IL6,
KDR,
PDGFRA,
PDGFRB,
TNF 💬		106件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85
544Pirfenidone Solution for Inhalation1件: Pirfenidone1件: D01583 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85
545Pirfenidone, deuterated1件: Pirfenidone1件: D01583 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85
546Pirfenidoneone----1件: 85
547Piribedil1件: Piribedil1件: D07305 2件: DRD2,
DRD3 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
548Piribedil (Clarium)1件: Piribedil1件: D07305 2件: DRD2,
DRD3 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
549Pitavastatin1件: Pitavastatin---1件: 49
550Pitolisant1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193
551Pitolisant Oral Tablet1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
552Pitolisant oral tablets1件: Pitolisant1件: D10749 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬1件: 193
553Pittsburgh Compound B1件: Pittsburgh Compound B---1件: 127
554Pittsburgh Compound B (C-11 PiB)1件: Pittsburgh Compound B---1件: 127
555PIXANTRONE1件: Pixantrone1件: D05522 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬2件: 11, 13
556PK-Merz----1件: 6
557PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj1件: Amantadine1件: D07441 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
558PKD Patients----1件: 6
559PKU Explore----1件: 240
560PKU express plus----1件: 240
561PKU Sphere----1件: 240
562PKU sphere liquid----1件: 240
563PKU Start----1件: 240
564PKU/TYR GMP Protein Substitute----1件: 240
565PL 00095/5079R----1件: 46
566PL 0010/0211----1件: 299
567PL 00512/0150----1件: 298
568PL 04515/0127----1件: 13
569PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)1件: Water1件: D00001 --1件: 57
570PL 12762/0049----1件: 13
571PL 17901/0122----1件: 96
572PL 20532/0012----1件: 96
573PL101----1件: 8
574PL8177----1件: 97
575PLA + MTX switched to ABA+ MTX, DB----1件: 46
576PLA-695----1件: 46
577PLA-PRU-PLA-PRU----1件: 99
578PLA-PRU-PRU-PLA----1件: 99
579Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276
580Placebo (physiological saline)----2件: 43, 45
581Placebo IV----1件: 50
582Placebo SC----1件: 50
583Placental Mesenchymal Stem Cells1件: Placental Mesenchymal Stem Cells---1件: 118
584Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix1件: Placental Mesenchymal Stem Cells---1件: 118
585PLACENTEX ® Polydeoxyribonucleotide----1件: 51
586PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml----1件: 51
587PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿----1件: 51
588Plaebo----1件: 46
589Plant cell expressed recombinant glucocerebrosidase (prGCD)1件: Taliglucerase alfa1件: D09675 1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
590Plant Cell Recombinant Glucocerebrosidase----1件: 19
591Plantago ovata husk----1件: 6
592Plantain NSP----1件: 96
593Plaquenil----4件: 46, 49, 53, 96
594Plaquenil - Hydroxychloroquine 200mg Film coated tablets1件: Hydroxychloroquine1件: D08050 --3件: 43, 44, 45
595Plaquenil 200 mg filmdrasjerte tabletter----1件: 46
596PLAQUENIL*25CPR RIV 200MG1件: Hydroxychloroquine1件: D08050 --1件: 84
597Plasma analysis for bacterial translocation----1件: 46
598Plasma exchange (PE)----1件: 64
599Plasma from healthy young people treatment + Riluzole1件: Riluzole1件: D00775 14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬1件: 2
600Plasma Lyso-GB3----1件: 19
601Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología PRGF-System (BTI)----1件: 96
602Plasma-derived FVIII/VWF concentrate----1件: 288
603PLASMASAFE----1件: 274
604PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----1件: 274
605Platelet enriched plasma----1件: 226
606Platelet Gel----1件: 51
607Platelet Rich Plasma----2件: 46, 90
608Platelet transfusion----1件: 13
609Platelet-Rich Plasma----1件: 226
610Platform----1件: 13
611Plecebo----1件: 256
612PLECONARIL1件: Pleconaril1件: D05528 --1件: 2
613PLEDIGRY----1件: 13
614Plegridy1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
615Plegridy (peginterferon beta-1a), Biogen Idec Ltd1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
616PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
617Plegridy 125 micrograms1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
618Plegridy 63 micrograms1件: Peginterferon beta-1a1件: D10483 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
619Plenadren 20 mg modified-release tablets2件: Hydrocortisone,
Manganese citrate		1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78
620Plenadren 5 mg modified-release tablets2件: Hydrocortisone,
Manganese citrate		1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78
621Pleneva TM BGC20-0134----1件: 13
622PLENUR----1件: 2
623PLERIXAFOR1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬4件: 20, 65, 285, 299
624Plerixafor for Conditioning before HSCT.1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
625Plerixafor mobilization of autologous CD117 stem cells1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 299
626PLETAL1件: Cilostazol1件: D01896 3件: PDE3A,
PDE3B,
TBXA2R 💬		14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
627PLF with NeoFuse----1件: 70
628PLN-748091件: PLN-74809---2件: 85, 94
629PLN-74809-0001件: PLN-74809---1件: 85
630PLN-74809-0201件: PLN-74809---1件: 85
631Plovamer acetate1件: Acetate---1件: 13
632Plovamer acetate 0.5 milligram (mg)1件: Acetate---1件: 13
633Plovamer acetate 10 mg1件: Acetate---1件: 13
634Plovamer acetate 20 mg1件: Acetate---1件: 13
635Plovamer acetate 3 mg1件: Acetate---1件: 13
636PLP----1件: 13
637PLP peptide----1件: 13
638PLX-200----1件: 19
639PLX-PAD1件: Placental Mesenchymal Stem Cells---1件: 86
640PLX3397----1件: 46
641PLX5622----1件: 46
642Plérixafor----1件: 285
643PMG1015 Dose 1----1件: 85
644PMG1015 Dose 2----1件: 85
645PMG1015 Dose 3----1件: 85
646PMG1015 Dose 4----1件: 85
647PMG1015 Dose 5----1件: 85
648PMG1015 Dose 6----1件: 85
649PMG1015 Dose 7----1件: 85
650PN 200 tablets (500 mg naproxen and 20 mg omeprazole)2件: Naproxen,
Omeprazole		2件: D00118 ,
D00455 		4件: ATP4A,
ATP4B,
PTGS1,
PTGS2 💬		26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271
651PN-101----1件: 50
652PN-10884A----1件: 97
653PN-180307----1件: 78
654PN-943----1件: 97
655PnCJ PPS----1件: 65
656Pnemovax----1件: 96
657PNEUMO 23----1件: 65
658Pneumo23----1件: 107
659Pneumo23 / Pneumovax----1件: 46
660Pneumococcal conjugate vaccine----1件: 46
661PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14
662PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE4件: Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein,
Phosphate ion		---1件: 46
663Pneumococcal polysaccharide serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F----1件: 46
664Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F----1件: 46
665Pneumococcal polysaccharide serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F----1件: 222
666Pneumococcal polysaccharide serotype 11 2.2 µg----1件: 222
667Pneumococcal polysaccharide vaccine----3件: 13, 46, 222
668PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)----1件: 46
669Pneumococcal polysaccharide vaccine 23 valent----1件: 265
670Pneumococcal polysaccharide vaccine solution for injection in a vial----1件: 222
671Pneumococcal serotypes----1件: 46
672Pneumovax----3件: 46, 49, 96
673Pneumovax 231件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---2件: 46, 50
674Pneumovax II----1件: 13
675PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----2件: 62, 66
676Pneumovax® (pneumococcal polysaccharide vaccine)----1件: 65
677PNEUMOVAX® 23----1件: 46
678PNU-215062 sodium salt----1件: 13
679PO----1件: 13
680PO azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
681PO ciprofloxacin1件: Ciprofloxacin1件: D00186 --1件: 299
682POL6014----1件: 299
683POL7080----1件: 299
684Polaprezinc1件: Polaprezinc1件: D01611 --2件: 96, 97
685Polidocanol1件: Polidocanol1件: D01993 --1件: 279
686Poly ICLC----1件: 34
687POLY(OXY-1,2-ETHANEDIYL), A----1件: 235
688POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-1件: Diethyl ether1件: D01772 --1件: 235
689POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DI1件: Diethyl ether1件: D01772 --1件: 235
690POLY(OXY-1,2-ETHANEDIYL), ALPHA-HYDRO-OMEGA-METHOXY, ETHER WITH N-[[[2-[[6-[[1-[3-[[3-(2,3-DIHYDROXYPROPOXY)PROPYL]AMINO]-3-OXOPROPYL]-2,5-DIOXO-3-PYRROLIDINYL]THIO]HEXYL]AMINO]ETHYL]AMINO]CARBONYL]-2-METHYLALANYL-TERIPARATIDE (2:1)2件: Diethyl ether,
Teriparatide		2件: D01772 ,
D06078 		1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
691Polyclonal IgG----1件: 65
692POLYDEOXYRIBONUCLEOTIDES----2件: 51, 70
693Polyethylene glycol1件: Polyethylene glycol1件: D03370 --7件: 6, 78, 96, 97, 235, 276, 299
694Polyethylene Glycol 33501件: Polyethylene glycol1件: D03370 --2件: 96, 299
695Polymerase chain reaction----2件: 65, 285
696Polymorphism Analysis----2件: 49, 60
697Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----1件: 13
698PolyMVA----1件: 2
699Polyphenon E----2件: 13, 36
700Polyphenon E®----1件: 97
701Pomalidomida1件: Pomalidomide1件: D08976 2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 51
702Pomalidomide1件: Pomalidomide1件: D08976 2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬5件: 28, 51, 85, 227, 331
703Pomalidomide (CC-40471件: Pomalidomide1件: D08976 2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 85
704Pomalidomide (CC-4047)1件: Pomalidomide1件: D08976 2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 51
705Pomalidomide and Dexamethasone2件: Dexamethasone,
Pomalidomide		2件: D00292 ,
D08976 		3件: IL6,
NR3C1,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
706Pomalidomide Oral Product1件: Pomalidomide1件: D08976 2件: IL6,
TNF 💬		80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 227
707PONESIMOD1件: Ponesimod1件: D11215 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
708Ponesimod 10 mg1件: Ponesimod1件: D11215 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
709Ponesimod 20 mg1件: Ponesimod1件: D11215 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
710Ponesimod 40 mg1件: Ponesimod1件: D11215 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
711Ponticelli Regimen----1件: 222
712Ponvory1件: Ponesimod1件: D11215 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
713Pooled mesenchymal stem cell----1件: 49
714Pooled Plasma (Human), Solvent/Detergent Treated----1件: 64
715Porcine (pig) PERT----1件: 299
716Porcine PERT----1件: 299
717Porphobilinogen1件: Porphobilinogen---1件: 254
718Posaconazole1件: Posaconazole1件: D02555 --3件: 60, 65, 299
719Posaconazole (PSZ)1件: Posaconazole1件: D02555 --1件: 65
720Posaconazole 100 MG [Noxafil]1件: Posaconazole1件: D02555 --1件: 299
721Posaconazole 40 MG/ML1件: Posaconazole1件: D02555 --1件: 299
722POSACONAZOLO----1件: 299
723Posiphen1件: Posiphen---1件: 6
724Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)1件: Activated charcoal---1件: 6
725Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----1件: 6
726Post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: D03879 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58
727Postoperative 3-month exclusive enteral nutrition----1件: 96
728Potassium1件: Potassium1件: D08403 --13件: 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235
729Potassium sparing diuretic1件: Potassium1件: D08403 --1件: 235
730Potassium supplement1件: Potassium1件: D08403 --1件: 46
731Potiga1件: Ezogabine1件: D09569 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬		6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬1件: 144
732Povetacicept----3件: 61, 63, 222
733Powder for Oral Suspension)----1件: 113
734Pozelimab1件: Pozelimab1件: D11477 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62
735Pozelimab + Cemdisiran2件: Cemdisiran,
Pozelimab		1件: D11477 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11
736PPI treatment----1件: 299
737PPS----1件: 65
738Pr----1件: 41
739PR Oxycodone1件: Oxycodone1件: D05312 3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
740PR-06410293----1件: 46
741PR1----1件: 51
742PRA023----3件: 51, 96, 97
743PRA023 IV----3件: 51, 96, 97
744PRALIA 60 mg Subcutaneous Injection Syringe(denosumab)1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 46
745PRALIA 60mg Subcutaneous Injection Syringe(denosumab)1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 46
746Praluent1件: Alirocumab1件: D10335 1件: PCSK9 💬1件: Cholesterol metabolism 💬1件: 79
747Pramipexol1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
748Pramipexol Extended Release1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
749Pramipexol Immediate Release1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
750Pramipexole1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 20
751Pramipexole 0.125 mg tablets1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
752Pramipexole 0.5 mg tablets1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
753PRAMIPEXOLE DIHYDROCHLORIDE1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
754Pramipexole dihydrochloride extended-release tablets1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
755PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
756Pramipexole dihydrochloride monohydrate extended release2件: Manganese citrate,
Pramipexole		1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
757Pramipexole ER1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
758Pramipexole Extended Release1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
759Pramipexole extended release tablet1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
760Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
761Pramipexole Immediate Release1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
762Pramipexole immediate release tablet1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
763Pramipexole IR1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
764Pramipexole or ropinirole2件: Pramipexole,
Ropinirole		2件: D05575 ,
D08489 		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
765Pramipexole SR1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
766Prasinezumab1件: Prasinezumab1件: D11420 1件: SNCA 💬3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6
767Prasterone1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49
768Prasterone (GL701)1件: Prasterone1件: D08409 3件: AR,
ESR1,
ESR2 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 49
769Pravastatin1件: Pravastatin1件: D08410 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333
770Pravastatin sodium1件: Pravastatin1件: D08410 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 265
771Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
772PRD2175434----1件: 113
773PRD4862257----1件: 46
774PRD5973697----1件: 97
775PRD7255830----1件: 79
776PRD7255977----1件: 79
777PRD7256003----1件: 79
778PRD806998----1件: 13
779Pre and post-CPB Drug: Dobutamine Hydrochloride1件: Dobutamine1件: D03879 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 58
780Pre-filled syringe----1件: 46
781Prebiotics----2件: 96, 97
782Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----1件: 13
783Precedentemente denominato MEDI2070 e AMG 139----1件: 96
784Precision dosing with a dashboard----1件: 96
785Pred----1件: 46
786Pred + Meth----1件: 46
787Predinose oral----1件: 70
788PredniHEXAL----1件: 46
789PredniHEXAL® 10mg Tabletten----1件: 46
790PredniHEXAL® 20mg Tabletten----1件: 46
791PredniHEXAL® 5mg Tabletten----1件: 46
792PredniHEXAL® 5mg Tabletten, PredniHEXAL® 10mg Tabletten----1件: 46
793PredniHEXAL® 5mg Tabletten, PredniHEXAL® 20mg Tabletten----1件: 46
794Predniso----1件: 46
795Prednisolene tablets BP 1 mg----1件: 46
796Prednisolon----7件: 46, 50, 51, 66, 95, 96, 97
797Prednisolon 1 mg JENAPHARM----1件: 41
798Prednisolon 10 mg JENAPHARM----1件: 41
799Prednisolon 20 mg JENAPHARM----1件: 41
800Prednisolon 5 mg JENAPHARM----1件: 41
801Prednisolon Jenapharm----2件: 96, 97
802Prednisolon Pfizer----2件: 46, 50
803Prednisolona1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51
804PREDNISOLONE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
805Prednisolone & dipyridamole2件: Dipyridamole,
Prednisolone		2件: D00302 ,
D00472 		3件: NR3C1,
PDE4A,
PDE5A 💬		7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
806Prednisolone + mabthera2件: Prednisolone,
Rituximab		2件: D00472 ,
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61
807Prednisolone 1mg Tablets1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
808Prednisolone 2,5 mg Tablets1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
809Prednisolone 20 mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
810Prednisolone 40 mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
811Prednisolone 5 mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51
812Prednisolone 5 mg JENAPHARM1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
813Prednisolone 5 mg Tablets1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
814Prednisolone 5mg Gastro-resistant Tablets1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51
815Prednisolone 5mg Tablet1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
816PREDNISOLONE ACETATE3件: Acetate,
Prednisolone,
Prednisolone acetate		2件: D00472 ,
D00980 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
817Prednisolone and chlorambucil2件: Chlorambucil,
Prednisolone		2件: D00266 ,
D00472 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
818Prednisolone and mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone		3件: D00472 ,
D00752 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 222
819Prednisolone and taper1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51
820Prednisolone Labesfal1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
821Prednisolone sodium metasulphobenzoate1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
822PREDNISOLONE SODIUM PHOSPHATE2件: Phosphate ion,
Prednisolone		1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 3, 13, 97
823PREDNISOLONE SODIUM SUCCINATE1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 95
824Prednisolone Tablets B.P. 5mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
825Prednisolone Tablets BP1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
826Prednisolone Tablets BP 1 mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
827Prednisolone Tablets USP 5 mg1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
828Prednisolone-Dipyridamole2件: Dipyridamole,
Prednisolone		2件: D00302 ,
D00472 		3件: NR3C1,
PDE4A,
PDE5A 💬		7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
829Prednisolone/Prednisone2件: Prednisolone,
Prednisone		2件: D00472 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
830Prednisoloni----1件: 51
831Prednisolonum1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 51
832Prednison----3件: 46, 84, 113
833Prednison 10 mg GALEN----1件: 35
834Prednison 5 mg GALEN----1件: 35
835PREDNISON 5, 20 Léciva por. tablet nob----1件: 50
836Prednison 5, 20 Léciva por. tablet nob.----1件: 50
837Prednison 50 mg GALEN----1件: 35
838Prednison acis® 20 mg----2件: 43, 44
839Prednison acis® 5 mg----2件: 43, 44
840Prednison acis¿ 20 mg----2件: 43, 44
841Prednison acis¿ 5 mg----2件: 43, 44
842Prednison20 mg GALEN----1件: 35
843Prednisona1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 46, 49, 222
844Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
845Prednisone (and methylprednisolone)2件: Methylprednisolone,
Prednisone		2件: D00407 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43
846Prednisone + Inhibace/Cozaar1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
847Prednisone - Azathioprine2件: Azathioprine,
Prednisone		2件: D00238 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 11
848Prednisone 0,5 mg/kg orally on alternate days1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
849Prednisone 1 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
850Prednisone 15 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
851Prednisone 2 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
852Prednisone 3 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
853Prednisone 4 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
854Prednisone 5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 66
855Prednisone 5 mg tablets1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
856Prednisone 7.5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
857Prednisone acetate3件: Acetate,
Prednisone,
Prednisone acetate		2件: D00473 ,
D08416 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 46, 49, 224
858Prednisone Acetate Tablets3件: Acetate,
Prednisone,
Prednisone acetate		2件: D00473 ,
D08416 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 224
859Prednisone alone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66
860Prednisone and Belimumab2件: Belimumab,
Prednisone		2件: D00473 ,
D03068 		2件: NR3C1,
TNFSF13B 💬		5件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Rheumatoid arthritis 💬1件: 300
861Prednisone and cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 ,
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
862Prednisone and Mycophenolate mofetil3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		3件: D00473 ,
D00752 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 300
863Prednisone and ustekinumab treatment2件: Prednisone,
Ustekinumab		2件: D00473 ,
D09214 		4件: IL12A,
IL12B,
IL23A,
NR3C1 💬		29件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Neuroactive ligand-receptor interaction, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 41
864PREDNISONE ARROW 20mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
865PREDNISONE ARROW 5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
866Prednisone Capsule1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
867Prednisone Capsules1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
868Prednisone discontinuation1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 49
869PREDNISONE DOC GENERICI - 5 MG COMPRESSE 10 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 19
870PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 300
871Prednisone in full dose1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
872Prednisone or Prednisolone2件: Prednisolone,
Prednisone		2件: D00472 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 66, 84
873Prednisone plus cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 ,
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
874Prednisone plus exercise1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 113
875PredniSONE Tablets USP, 1 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46
876PredniSONE Tablets USP, 10 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
877PredniSONE Tablets USP, 1mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
878PredniSONE Tablets USP, 2.5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
879PredniSONE Tablets USP, 2.5mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
880PredniSONE Tablets USP, 20mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
881PredniSONE Tablets USP, 5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 41, 46
882PredniSONE Tablets USP, 5mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
883PredniSONE Tablets, USP1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 41, 43, 44
884PredniSONE Tablets, USP 10 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
885PredniSONE Tablets, USP 2.5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
886PredniSONE Tablets, USP 5 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
887PredniSONE Tablets, USP, 1 mg1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
888Prednisone therapy and pharmacokinetic1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
889Prednisone treatment1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 41
890Prednisone with daily edasalonexent2件: Edasalonexent,
Prednisone		2件: D00473 ,
D12181 		2件: NR3C1,
RELA 💬		77件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, Mitophagy - animal, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬1件: 113
891Prednisone, ciclosporin and mycophenolate mofetil4件: Cyclosporine,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		4件: D00184 ,
D00473 ,
D00752 ,
D05096 		8件: IMPDH1,
IMPDH2,
NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		38件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222
892Prednisone, cyclophosphamide2件: Cyclophosphamide,
Prednisone		3件: D00287 ,
D00473 ,
D07760 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 40
893Prednisone, FK506, MMF1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
894Prednisone, low dose rituximab2件: Prednisone,
Rituximab		2件: D00473 ,
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 61
895Prednisone, methylprednisolone,cyclophosphamides2件: Methylprednisolone,
Prednisone		2件: D00407 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45
896Prednisone/Prednisolone2件: Prednisolone,
Prednisone		2件: D00472 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35
897Prednizolon----1件: 51
898Prednizolonas----1件: 51
899Prefilled liquid etanercept(Yisaipu)2件: Etanercept,
Yisaipu		1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
900Prefilled Syringe delivery of Golimumab1件: Golimumab1件: D04358 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
901Prefolic----1件: 337
902PREFOLIC 15*30CPR GASTROR 15MG----1件: 337
903PREFOLIC*30CPR GASTROR 15MG----1件: 299
904Pregabalin1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298
905Pregabalin 75mg1件: Pregabalin1件: D02716 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70
906Preimplantation factor1件: Preimplantation factor---1件: 95
907Preladenant1件: Preladenant1件: D09717 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6
908Preladenant 10 mg tablet1件: Preladenant1件: D09717 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6
909Preladenant 2 mg tablet1件: Preladenant1件: D09717 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6
910Preladenant 5 mg tablet1件: Preladenant1件: D09717 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6
911Premarin and Provera----1件: 49
912Premarin ®----1件: 6
913PREOTACT1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
914Preparative regimen 4-6 weeks after Leukapheresis----1件: 96
915Prepulsid----1件: 13
916Prescribe N-acetylcysteine tablets1件: Acetylcysteine1件: D00221 --1件: 90
917Preservative free artificial tear gel.----1件: 157
918PREVENAR----1件: 65
919Prevenar 131件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---5件: 13, 14, 46, 96, 222
920PREVENAR 13 - 0.5 ML SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - FLACONCINO MONODOSE (0,5 ML VETRO TIPO I) - 1 FLACONCINO MONODOSE1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 222
921Prevenar 13 sospensione per iniezione1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 14
922Prevenar 13 suspension for injection1件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen---1件: 222
923Prevenar vaccination----1件: 46
924Prevenar vaccine----1件: 46
925Prevenar13----2件: 19, 265
926Prevenar® (7-valent pneumococcal conjugate vaccine)----1件: 65
927Prevenar® and Pneumo23®----1件: 49
928Previously known as R935788----1件: 46
929Previously referred to as MEDI2070 and AMG 139----2件: 96, 97
930Previously referred to as MEDI2070 and AMG 139, AGN-151-598----1件: 96
931Previously termed sc.AAV9.CB.SMN and AVXS-101----1件: 3
932PrGCD1件: Taliglucerase alfa1件: D09675 1件: GBA1 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
933Pridia (Donepezil Hydrochloride) 5mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6
934Pridia 10mg----1件: 6
935Pridia 5mg----1件: 6
936Pridiopidine----1件: 8
937Pridopidina----1件: 8
938Pridopidine1件: Pridopidine1件: D09953 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 8
939Pridopidine (90 mg)1件: Pridopidine1件: D09953 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8
940PRIDOPIDINE HYDROCHLORIDE1件: Pridopidine1件: D09953 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8
941PRIM-DJ2727----2件: 6, 97
942Primary Cervical Dystonia (Trihexyphenidyl)1件: Trihexyphenidyl1件: D08638 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 6
943Primavanserin tartrate----1件: 6
944PrimeC----1件: 2
945Primidone1件: Primidone1件: D00474 --1件: 2
946Prior Donepezil 5mg1件: Donepezil1件: D07869 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6
947Prior Donzepezil 10mg----1件: 6
948PRIVIGEN1件: Human immunoglobulin G---4件: 11, 14, 51, 65
949PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML----1件: 51
950Privigen 100 mg/ml, solution pour perfusion----1件: 53
951PRIVIGEN 100mg/ml----1件: 85
952Privigen®1件: Human immunoglobulin G---3件: 14, 63, 65
953PRM-1511件: PRM-151---1件: 85
954PRM-151 (Zinpentraxin Alfa)1件: PRM-151---1件: 85
955PRN1008----2件: 35, 61
956PRN1008 (Rilzabrutinib)----1件: 35
957PRN1008 Freebase----1件: 35
958PRN2246----2件: 11, 13
959PRO044----1件: 113
960PRO044 IV----1件: 113
961PRO044 IV 6 mg/kg----1件: 113
962PRO044 IV 9 mg/kg----1件: 113
963PRO044 SC----1件: 113
964PRO044 SC 6 mg/kg----1件: 113
965PRO0451件: BMN-045---1件: 113
966PRO045, 0.15 mg/kg/week1件: BMN-045---1件: 113
967PRO045, 1.0 mg/kg/week1件: BMN-045---1件: 113
968PRO045, 3.0 mg/kg/week1件: BMN-045---1件: 113
969PRO045, 6.0 mg/kg/week1件: BMN-045---1件: 113
970PRO045, 9.0 mg/kg/week1件: BMN-045---1件: 113
971PRO045, selected dose1件: BMN-045---1件: 113
972PRO051----1件: 113
973PRO053----1件: 113
974PRO145223----1件: 97
975PRO145223 (RO5490261)----1件: 97
976PRO283698----1件: 46
977Probenecid1件: Probenecid1件: D00475 --1件: 25
978Probiotic----8件: 2, 6, 93, 96, 97, 193, 266, 299
979Probiotic - VSL#3----1件: 96
980Probiotic Capsule----1件: 6
981Probiotic capsules containing Lactobacillus rhamnosus GR-1 and L. reuteri RC-141件: Lactobacillus delbrueckii bulgaricus---1件: 46
982Probiotic Formula Capsule----1件: 97
983Probiotic group----1件: 271
984Probiotic Mixture----2件: 96, 97
985Probiotic Product - Cap----1件: 53
986Probiotic-Lactobacillus plantarum PS1281件: Lactobacillus plantarum---1件: 156
987Probiotics----5件: 6, 94, 96, 97, 291
988Probiotics (Visbiome®)----1件: 13
989Probiotics with prebiotic----1件: 6
990Probucol1件: Probucol1件: D00476 --1件: 66
991Procaptan----1件: 58
992PROCAPTAN - 10 MG COMPRESSE RIVESTITE CON FILM 60 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58
993PROCAPTAN - 5 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN CONTENITORE PER COMPRESSE PP----1件: 58
994Procarbazine1件: Procarbazine1件: D08423 --1件: 65
995Prochymal1件: Remestemcel-L1件: D09719 --1件: 96
996PROCHYMAL (remestemcel-L)1件: Remestemcel-L1件: D09719 --1件: 96
997PROCHYMAL adult human mesenchymal stem cells1件: Remestemcel-L1件: D09719 --1件: 96
998Prochymal®1件: Remestemcel-L1件: D09719 --1件: 96
999Prochymal™ adult human mesenchymal stem cells1件: Remestemcel-L1件: D09719 --1件: 96
1000PROCYSBI1件: Cysteamine1件: D03634 --1件: 19
1001Prodarsan----1件: 192
1002Products containing aminosalicylate----1件: 97
1003Products containing azathioprine or 6-mercaptopurine2件: Azathioprine,
Mercaptopurine		3件: D00161 ,
D00238 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97
1004Profilassi per Herpes Zoster----1件: 107
1005Progerinin----2件: 191, 333
1006Progesterone1件: Progesterone1件: D00066 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬2件: 76, 299
1007Proglumide1件: Proglumide1件: D01818 1件: CCKBR 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬1件: 298
1008Prograf1件: Tacrolimus2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬3件: 60, 222, 226
1009Prograft capsules----1件: 299
1010Progressive spacing of TNF-blocker injections----1件: 46
1011Progynova 21 mite----1件: 65
1012Prohance (Gadoteridol)1件: Gadoteridol1件: D01137 --1件: 13
1013Prolastin----3件: 231, 298, 299
1014Prolastin (drug)----1件: 299
1015Prolastin-C1件: Alpha-1-proteinase inhibitor---2件: 231, 298
1016Prolastin-C, 120 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231
1017Prolastin-C, 60 mg/kg1件: Alpha-1-proteinase inhibitor---1件: 231
1018Proleukin1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬3件: 2, 49, 65
1019Proleukin 18 MUI1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 2
1020PROLEUKIN® S1件: Aldesleukin1件: D00748 3件: IL2RA,
IL2RB,
IL2RG 💬		14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 65
1021Prolia1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274
1022Proline1件: Proline1件: D00035 --2件: 94, 97
1023Prolonged release tablet1件: Manganese citrate---1件: 6
1024Prolonged-release Fampridine1件: Dalfampridine1件: D04127 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13
1025Prolopa®----1件: 6
1026Prolotherapy solution of 20% dextrose1件: Dextrose, unspecified form---1件: 70
1027Promacta1件: Eltrombopag---2件: 63, 65
1028Promethazine1件: Promethazine1件: D00494 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 96
1029Promethera HepaStem----1件: 251
1030Prometic's Immune Globulin Intravenous 10%----1件: 65
1031Promiten----1件: 97
1032Promixin----1件: 299
1033Promixin 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1034PROMIXIN*NEBUL 30MONOD 1MUI----1件: 299
1035Promixin, 1 million International Units (IU) Powder for Nebuliser Solution----1件: 299
1036Promixin,1 millón de Unidades Internacionales,polvo para solución para inhalación por nebulizador----1件: 299
1037Promixin/Tadim----1件: 299
1038Propanoic acid2件: Naproxen,
Propanoic acid		1件: D00118 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 6, 271
1039Propanolol1件: Propranolol1件: D08443 3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 296
1040Propantheline1件: Propantheline---1件: 26
1041Propantheline Bromide1件: Propantheline---1件: 26
1042Prophylactic Corticosteroid Taper Regimen----1件: 251
1043Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----1件: 13
1044PROPIONYL L-CARNITINE1件: Levocarnitine1件: D02176 --1件: 97
1045PROPIONYL L-CARNITINE HYDROCHLORIDE1件: Levocarnitine1件: D02176 --1件: 97
1046Propionyl-L-Carnitine2件: Levocarnitine,
Levocarnitine propionate		1件: D02176 --1件: 97
1047Propionylcarnitinhydrochlorid----1件: 97
1048Propiverine1件: Propiverine1件: D08441 9件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		43件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
1049Propiverine Hydrochloride1件: Propiverine1件: D08441 9件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		43件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
1050PROPOFOL1件: Propofol1件: D00549 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬8件: 6, 21, 22, 34, 46, 70, 98, 296
1051Propofol Injection1件: Propofol1件: D00549 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 70
1052Propofol-Lipuro1件: Propofol1件: D00549 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 6
1053Propolipid----1件: 46
1054Proposed INN - FILGOTINIB1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
1055Propranolol1件: Propranolol1件: D08443 3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 158, 167, 227, 278
1056Propranolol HCl CF 40 mg tablet1件: Propranolol1件: D08443 3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6
1057Propranolol treatment1件: Propranolol1件: D08443 3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 227
1058Propsoed INN - FILGOTINIB1件: Filgotinib1件: D10871 1件: JAK1 💬27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
1059Propylene glycol1件: Propylene glycol1件: D00078 --1件: 51
1060ProSavin----1件: 6
1061PROSCAR*30CPR RIV 5MG1件: Finasteride1件: D00321 1件: SRD5A2 💬3件: Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬1件: 6
1062Prostacyclin1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
1063Prostacyclin Receptor Agonist1件: Epoprostenol1件: D00106 1件: PTGIR 💬3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86
1064Prostanoids----1件: 51
1065PROTEASA----1件: 299
1066PROTEASE----1件: 299
1067Protease inhibitor----1件: 265
1068Protease inhibitors----1件: 265
1069ProTectis----1件: 66
1070Protein----2件: 46, 67
1071Protein intake----1件: 240
1072Protein-carbohydrate supplementation----1件: 113
1073Proteína recombinante estimulante de la megacariopoyesis----1件: 63
1074Prothrombin1件: Prothrombin---1件: 288
1075Prothrombin Complex Concentrate2件: Factor IX Complex (Human),
Prothrombin		---1件: 288
1076Proton pump inhibitor (PPI)----1件: 298
1077Prototype capsule GDC-01341件: GDC-0134---1件: 2
1078Provigil1件: Modafinil1件: D01832 --2件: 13, 113
1079Provigil (modafinil)1件: Modafinil1件: D01832 --1件: 13
1080PROVIGIL - 100 MG COMPRESSE 30 COMPRESSE1件: Modafinil1件: D01832 --1件: 113
1081PROZAC----1件: 17
1082PRP----1件: 90
1083PRP injection----1件: 53
1084PRTX-100----1件: 46
1085PRTX-100 (Staphylococcal protein A)1件: Bevifimod---1件: 63
1086PRTX-100 at 1.5 mcg/kg----1件: 46
1087PRTX-100 at 12.0 mcg/kg----1件: 46
1088PRTX-100 at 240 mcg----1件: 46
1089PRTX-100 at 3.0 mcg/kg----1件: 46
1090PRTX-100 at 420 mcg----1件: 46
1091PRTX-100 at 6.0 mcg/kg----1件: 46
1092PRU-PLA-PLA-PRU----1件: 99
1093PRU-PLA-PRU-PLA----1件: 99
1094PRUCALOPRIDE1件: Prucalopride1件: D09205 1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬3件: 13, 51, 96
1095PRUCALOPRIDE SUCCINATE1件: Prucalopride1件: D09205 1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 51
1096PRV-300----1件: 97
1097PRV-6527----1件: 96
1098PRV-6527 (JNJ-40346527)1件: JNJ-40346527---1件: 96
1099PRV-6527(JNJ-40346527)1件: JNJ-40346527---1件: 96
1100PRX-102----1件: 19
1101PRX-102 (pegunigalsidase alfa)1件: Pegunigalsidase alfa1件: D11685 --1件: 19
1102PRX-102 1 mg/kg every 2 weeks----1件: 19
1103PRX-102 2 mg/kg every 4 weeks----1件: 19
1104PRX-112----1件: 19
1105PRX002----1件: 6
1106PRX002, ELT2, anti-alpha-synuclein monoclonal antibody----1件: 6
1107PRX102----1件: 19
1108PS----2件: 90, 97
1109PS-QD----1件: 97
1110PS-SP----1件: 97
1111PS128----1件: 6
1112PS188----1件: 113
1113PS188 (company code)----1件: 113
1114PS220----1件: 113
1115PS524----1件: 113
1116PsAer IgY----1件: 299
1117Pseudoephedrine1件: Pseudoephedrine1件: D08449 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
1118Pseudoephedrine + 480 ml water2件: Pseudoephedrine,
Water		2件: D00001 ,
D08449 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
1119Pseudoephedrine + 50 ml water2件: Pseudoephedrine,
Water		2件: D00001 ,
D08449 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
1120Psilocybin1件: Psilocybin---1件: 6
1121Psilocybin therapy1件: Psilocybin---1件: 6
1122Psilocybine1件: Psilocybin---1件: 6
1123Psorcutan-Ointment----1件: 36
1124PSRS11.EFS.IL2RG.pre* retroviral vector----1件: 65
1125PSRS11.EFS.IL2RG.pre* retroviral vector transduce----1件: 65
1126PSRS11.EFS.IL2RG.pre* retroviral vector transduced cells----1件: 65
1127Psyllium1件: Plantago seed1件: D05525 --3件: 6, 28, 97
1128Psyllium husk1件: Plantago seed1件: D05525 --1件: 97
1129Psyllium Husk Powder1件: Plantago seed1件: D05525 --1件: 97
1130PT320 2.0 mg----1件: 6
1131PT320 2.5 mg----1件: 6
1132PTC-0161480----2件: 246, 299
1133PTC-124----2件: 246, 299
1134PTC-C124----2件: 246, 299
1135PTC0161480, PTC124 Compound 1a, RPS2505, PTC-C124, 291844----1件: 113
1136PTC124----4件: 19, 113, 246, 299
1137PTC2991件: PTC299---1件: 34
1138PTC518----1件: 8
1139PTC518 tablet 20 mg----1件: 8
1140PTC518 tablet 5 mg----1件: 8
1141PTC743----2件: 18, 21
1142PTC857----1件: 2
1143PTC857 oral solution----1件: 2
1144PTC923----1件: 240
1145PTG-100----1件: 97
1146PTG-200----1件: 96
1147PTH----2件: 65, 235
1148PTH 1-341件: Teriparatide1件: D06078 1件: PTH1R 💬3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 65, 235
1149PTH1-84 in parent study----1件: 235
1150PTI-4281件: PTI-428---1件: 299
1151PTI-8011件: PTI-801---1件: 299
1152PTI-808----1件: 299
1153PTL201----1件: 13
1154PTR-01----1件: 36
1155PTW-002 10 mg/g gel----1件: 36
1156PU-AD----1件: 2
1157Puerarin1件: Puerarin---1件: 46
1158Puerarin injection 400 mg1件: Puerarin---1件: 46
1159Puerarin tablet 50 mg1件: Puerarin---1件: 46
1160Pulmaquin®----1件: 299
1161Pulmozyme1件: Dornase alfa1件: D03896 --1件: 299
1162Pulmozyme (dornase alfa)1件: Dornase alfa1件: D03896 --1件: 299
1163Pulmozyme (Dornase alpha)1件: Dornase alfa1件: D03896 --1件: 299
1164Pulmozyme single use ampule1件: Dornase alfa1件: D03896 --1件: 299
1165Pulmozyme®1件: Dornase alfa1件: D03896 --1件: 299
1166PUR 0110----1件: 97
1167PUR 0110 Rectal Enema----1件: 97
1168PUR 0110 Rectal Enema 1000 mg----1件: 97
1169PUR 0110 Rectal Enema 250 mg----1件: 97
1170PUR 0110 Rectal Enema 500 mg----1件: 97
1171PUR118----1件: 299
1172Puri Nethol----1件: 96
1173Puri-Nethol----3件: 86, 96, 97
1174Puri-Nethol 50 mg----1件: 96
1175Purified form of the lysosomal enzyme iduronate-2-sulfatase----1件: 19
1176Purified Vero Cell Vaccine)----1件: 65
1177PURINETHOL1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96
1178PURINETHOL - 50 MG COMPRESSE25 COMPRESSE1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 96
1179PV----1件: 97
1180PXL065----1件: 20
1181PXL770----1件: 20
1182PXT002331----1件: 6
1183PXT002331 - 20mg----1件: 6
1184PXT002331 - dose 1----1件: 6
1185PXT002331 - dose 2----1件: 6
1186PXT3003----1件: 10
1187PXT3003 Dose 1----1件: 10
1188PXT3003 Dose 2----1件: 10
1189PXT3003 Dose 2 (equivalent to twice Dose 1)----1件: 10
1190PXT3003 High Dose----1件: 10
1191PXT3003 Intermediate Dose----1件: 10
1192PXT3003 Low dose----1件: 10
1193PYM50028----1件: 6
1194Pyrazole1件: Pyrazole---1件: 58
1195Pyridostigmine1件: Pyridostigmine---4件: 3, 6, 11, 256
1196Pyridostigmine Bromide1件: Pyridostigmine---3件: 3, 6, 256
1197Pyridostigmine, Prednisone, Tacrolimus3件: Prednisone,
Pyridostigmine,
Tacrolimus		3件: D00107 ,
D00473 ,
D08556 		6件: NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11
1198Pyridostigmine, Tacrolimus2件: Pyridostigmine,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 11
1199PYRIDOXINE1件: Pyridoxine1件: D08454 --3件: 93, 145, 320
1200Pyridoxine 10mg1件: Pyridoxine1件: D08454 --1件: 93
1201Pyridoxine 10mg BP1件: Pyridoxine1件: D08454 --1件: 93
1202Pyridoxine plus prednisolone2件: Prednisolone,
Pyridoxine		2件: D00472 ,
D08454 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 145
1203PYRIMETHAMINE1件: Pyrimethamine1件: D00488 --4件: 2, 4, 19, 65
1204Pyrophosphate----1件: 51
1205Pyrrolidine1件: Pyrrolidine---2件: 28, 97
1206Pyruvate, creatine, niacinamide2件: Creatine,
Nicotinamide		1件: D00036 --1件: 5
1207PyVST----1件: 25
1208PZN 8881655(RochePharma AG)----1件: 85